Ciox Health (PRIVATE.CIOX)

Overall impact
B (61)

Commentary

Ciox Health is a strong overall performer. With a 'B' rating of 61.1 for overall impact (65th percentile compared to all companies), Ciox Health ranks 51st out of 96 industry peers, behind Suvoda, Gainwell Technologies, Healthequity and 47 others, and ahead of Maximus, NantHealth, Bionano Genomics and 42 others. On top material causes for Ciox Health's industry (Healthcare Software & Services), Ciox Health performs well in Quality Lifelong Education (90.9 score), Improved Mental Health (95.3), Child and Maternal Health (95.0) and 2 other causes where it received an 'A' score and performs poorly in Sustainable Use of Natural Resources (19.6 score), Reduced Waste (30.2), Accountable Institutions (12.6) and 4 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.CIOX
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2016
Employees
35
Sector
Health Care
Industry
Health Care Technology
Sub-industry
Health Care Technology
SASB industry
Software & IT Services
Headquarters
Georgia, United States
Share classes
PRIVATE.CIOX
Description
Provider of healthcare data management services intended to serve hospitals, patients, and healthcare clinics. The company makes clinical source data accessible by converting it into research-grade information, enabling clients to validate existing evidence and support decision-making on medical care interventions.
Material causes
Ethos considers the following causes material for Ciox Health, based on its industry sub-industry Health Care Technology. Learn more about material causes in our methodology overview.
Not available

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.